2016. NON-INVASIVE MONITORING OF EGFR MUTATIONS IN NONSMALL CELL LUNG CANCER (NSCLC) DURING TARGETED THERAPY: STATE OF THE ART AND OUR EXPERIENCE. Voprosy onkologii. 62, 4 (Dec. 2016), 513–518. DOI:https://doi.org/10.37469/0507-3758-2016-62-4-513-518.